Commentaries
Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis
Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas
R. Salido Vallejo
Servicio de Dermatología, Hospital Reina Sofía, Córdoba, España
Read
4737
Timeswas read the article
1820
Total PDF
2917
Total HTML
Share statistics
array:24 [ "pii" => "S1578219018300209" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.018" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1857" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 65 "formatos" => array:2 [ "HTML" => 63 "PDF" => 2 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017306282" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.11.005" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1857" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 180 "formatos" => array:2 [ "HTML" => 122 "PDF" => 58 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "200" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. Salido Vallejo" "autores" => array:1 [ 0 => array:2 [ "nombre" => "R." "apellidos" => "Salido Vallejo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219018300209" "doi" => "10.1016/j.adengl.2018.02.018" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300209?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306282?idApp=UINPBA000044" "url" => "/00017310/0000010900000003/v1_201804020403/S0001731017306282/v1_201804020403/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219018300398" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.022" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1878" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 63 "formatos" => array:2 [ "HTML" => 62 "PDF" => 1 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-vs-Host Disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "200" "paginaFinal" => "201" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Imatinib: Una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Ferrándiz-Pulido" "autores" => array:1 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Ferrándiz-Pulido" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017306750" "doi" => "10.1016/j.ad.2017.12.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306750?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300398?idApp=UINPBA000044" "url" => "/15782190/0000010900000003/v1_201804020430/S1578219018300398/v1_201804020430/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S157821901830009X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.007" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1737" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:199" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 68 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 64 "PDF" => 3 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentary</span>" "titulo" => "Broadening the Sonographic Spectrum of Vascular Anomalies" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "199" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ampliando el espectro ecográfico de las anomalías vasculares" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Alfageme" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Alfageme" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017303472" "doi" => "10.1016/j.ad.2017.06.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017303472?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901830009X?idApp=UINPBA000044" "url" => "/15782190/0000010900000003/v1_201804020430/S157821901830009X/v1_201804020430/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "200" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "R. Salido Vallejo" "autores" => array:1 [ 0 => array:3 [ "nombre" => "R." "apellidos" => "Salido Vallejo" "email" => array:1 [ 0 => "rsalidovallejo@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Reina Sofía, Córdoba, España" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Actinic keratoses are intraepidermal skin tumors that appear in the context of a type of chronic actinic damage known as field cancerization. New treatments tend to cover not only clinically visible lesions, but also those that harbor subclinical dysplastic changes. Therefore, classic drugs such as imiquimod have returned to the fore because of their formulation, which is available in various concentrations,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">1</span></a> and the search for an optimal regimen that enables us to adapt the inflammatory reaction as much as possible to the clinical response.</p><p id="par0010" class="elsevierStylePara elsevierViewall">In this article, Serra-Guillén et al.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">2</span></a> investigate a new regimen of imiquimod 5% cream for the treatment of actinic keratosis. The authors propose a concentrated regimen in which they apply the drug daily for 12 consecutive days with the aim of finding a better response to therapy and a shorter duration of local cutaneous responses. The data obtained show the regimen to be slightly more effective than that reported in the summary of product characteristics, albeit at the cost of poorer tolerance. Furthermore, the linear correlation between the severity of the local reactions and the degree of clinical response can help us to predict the response to imiquimod, which is sometimes quite erratic, depending on the patient. In this interesting article, our colleagues from Instituto Valenciano de Oncología use high-quality data to reinforce the trend observed in daily clinical practice and the philosophy of “no pain, no gain”, which we try to transmit to patients so that a correct understanding of the mechanism of action of this drug leads to appropriate adherence and, therefore, a successful outcome.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Salido Vallejo R. Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas. Actas Dermosifiliogr. 2018;109:200.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:2 [ 0 => array:3 [ "identificador" => "bib0015" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Imiquimod 3.75% in actinic keratosis: Efficacy in patients with and without rest periods during treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Dirschka" 1 => "K. Peris" 2 => "G. Gupta" 3 => "A. Alomar" 4 => "S. Aractingi" 5 => "R. Dakovic" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jdv.13260" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2016" "volumen" => "30" "paginaInicial" => "1416" "paginaFinal" => "1417" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26303677" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0020" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Serra-Guillén C, Nagore E, Llombart B, Sanmartin O, Requena C, Calomarde L, et al. Tratamiento con Imiquimod al 5% durante 12 días para las queratosis actínicas: estudio de la eficacia y la reacción local. Actas Dermosifiliogr. 2017" ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000003/v1_201804020430/S1578219018300209/v1_201804020430/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000003/v1_201804020430/S1578219018300209/v1_201804020430/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300209?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 8 | 7 | 15 |
| 2024 October | 85 | 37 | 122 |
| 2024 September | 69 | 26 | 95 |
| 2024 August | 102 | 56 | 158 |
| 2024 July | 79 | 32 | 111 |
| 2024 June | 78 | 26 | 104 |
| 2024 May | 64 | 31 | 95 |
| 2024 April | 62 | 30 | 92 |
| 2024 March | 82 | 25 | 107 |
| 2024 February | 67 | 31 | 98 |
| 2024 January | 69 | 36 | 105 |
| 2023 December | 69 | 13 | 82 |
| 2023 November | 76 | 27 | 103 |
| 2023 October | 60 | 19 | 79 |
| 2023 September | 67 | 29 | 96 |
| 2023 August | 45 | 14 | 59 |
| 2023 July | 52 | 30 | 82 |
| 2023 June | 53 | 27 | 80 |
| 2023 May | 61 | 27 | 88 |
| 2023 April | 62 | 17 | 79 |
| 2023 March | 67 | 28 | 95 |
| 2023 February | 60 | 28 | 88 |
| 2023 January | 46 | 28 | 74 |
| 2022 December | 51 | 42 | 93 |
| 2022 November | 28 | 34 | 62 |
| 2022 October | 33 | 20 | 53 |
| 2022 September | 19 | 36 | 55 |
| 2022 August | 31 | 37 | 68 |
| 2022 July | 23 | 33 | 56 |
| 2022 June | 22 | 30 | 52 |
| 2022 May | 49 | 33 | 82 |
| 2022 April | 53 | 43 | 96 |
| 2022 March | 48 | 63 | 111 |
| 2022 February | 31 | 32 | 63 |
| 2022 January | 51 | 38 | 89 |
| 2021 December | 36 | 49 | 85 |
| 2021 November | 53 | 50 | 103 |
| 2021 October | 52 | 53 | 105 |
| 2021 September | 29 | 36 | 65 |
| 2021 August | 38 | 45 | 83 |
| 2021 July | 37 | 38 | 75 |
| 2021 June | 33 | 32 | 65 |
| 2021 May | 46 | 43 | 89 |
| 2021 April | 71 | 76 | 147 |
| 2021 March | 96 | 32 | 128 |
| 2021 February | 74 | 33 | 107 |
| 2021 January | 45 | 45 | 90 |
| 2020 December | 52 | 41 | 93 |
| 2020 November | 54 | 32 | 86 |
| 2020 October | 25 | 15 | 40 |
| 2020 September | 27 | 17 | 44 |
| 2020 August | 39 | 27 | 66 |
| 2020 July | 26 | 20 | 46 |
| 2020 June | 39 | 30 | 69 |
| 2020 May | 11 | 9 | 20 |
| 2020 April | 22 | 14 | 36 |
| 2020 March | 24 | 16 | 40 |
| 2020 February | 4 | 0 | 4 |
| 2020 January | 3 | 0 | 3 |
| 2019 December | 8 | 0 | 8 |
| 2019 November | 6 | 0 | 6 |
| 2019 September | 10 | 0 | 10 |
| 2019 August | 3 | 0 | 3 |
| 2019 July | 7 | 2 | 9 |
| 2019 June | 4 | 0 | 4 |
| 2019 May | 6 | 0 | 6 |
| 2019 April | 2 | 0 | 2 |
| 2019 March | 2 | 0 | 2 |
| 2019 February | 2 | 0 | 2 |
| 2018 December | 2 | 0 | 2 |
| 2018 November | 2 | 0 | 2 |
| 2018 October | 1 | 0 | 1 |
| 2018 September | 2 | 0 | 2 |
| 2018 April | 2 | 0 | 2 |
Show all
